1. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group trial EST 1684;Kirkwood;J Clin Oncol,1996
2. The history of cancer immunotherapy;Oettgen,1991
3. Antigenic properties of methylcholanthrene-induced tumours in mice of the strain of origin;Foley;Cancer Res,1953
4. Immunity to methylcholanthrene-induced sarcomas;Prehn;J Natl Cancer Inst,1957
5. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin;Hewitt;Br J Cancer,1976